Purdue, Monon Bioventures, Genezen use $400K to team up against tumor
A made-in-Indiana business story—and one of the state’s first ventures in gene therapy—could save the lives of patients with a devastating brain tumor who typically have little over a year to live “if they’re lucky,” says one researcher. The development of a potential treatment for glioblastoma marks the first time in Indiana that every link […]... Read More